Hadasit Bio HoldingsHSITF 14 3-Year ROIIC % is -4.36 as of Dec. 2025. GuruFocus rates HSITF with a GF Score™ of 14/100. The stock has 3 warning signs investors should review. Among 1,328 Biotechnology companies, Hadasit Bio Holdings ranks better than 50.38% on this metric.
3-Year Return on Invested Incremental Capital (3-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 3-year.
Hadasit Bio Holdings's 3-Year ROIIC % for the quarter that ended in Dec. 2025 was -4.36%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
The industry rank for Hadasit Bio Holdings's 3-Year ROIIC % or its related term are showing as below:
HSITF's 3-Year ROIIC % is ranked better than 50.38% of 1328
companies
in the Biotechnology industry
Industry Median: -4.9
vs HSITF: -4.36
Hadasit Bio Holdings (OTCPK:HSITF) 3-Year ROIIC % Explanation
Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.
High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
Be Aware
It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.
Hadasit Bio Holdings 3-Year ROIIC % Related Terms
Hadasit Bio Holdings 3-Year ROIIC % Historical Data
* Premium members only.
The historical data trend for Hadasit Bio Holdings's 3-Year ROIIC % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
HSITF vs VRTX, REGN, ALNY: 3-Year ROIIC % Comparison
For the Biotechnology subindustry, Hadasit Bio Holdings's 3-Year ROIIC %, along with its competitors' market caps and 3-Year ROIIC % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Hadasit Bio Holdings 3-Year ROIIC % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Hadasit Bio Holdings's 3-Year ROIIC % distribution charts can be found below:
* The bar in red indicates where Hadasit Bio Holdings's 3-Year ROIIC % falls into.
Hadasit Bio Holdings's 3-Year ROIIC % for the quarter that ended in Dec. 2025 is calculated as:
3-Year ROIIC %
=
3-Year Incremental Net Operating Profit After Taxes (NOPAT)**
/
3-Year Incremental Invested Capital**
=
( -0.562 (Dec. 2025) - -0.9074324 (Dec. 2022) )
/
( 0.381 (Dec. 2025) - 8.291 (Dec. 2022) )
=
0.3454324
/
-7.91
=
-4.37%***
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
** Annual data of NOPAT and Invested Capital was used to calculate 3-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.
Hadasit Bio Holdings (HSITF) has a 3-Year ROIIC % of -4.36 as of Dec. 2025. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on Hadasit Bio Holdings and its competitors. According to the industry distribution chart, Hadasit Bio Holdings ranks #659 out of 1328 companies in the Biotechnology industry, placing it in the top 49.6%.
Is Hadasit Bio Holdings' 3-Year ROIIC % too high?
Hadasit Bio Holdings' current 3-Year ROIIC % is -4.36. Based on the distribution chart, Hadasit Bio Holdings ranks #659 out of 1328 companies in the Biotechnology industry, which is above the industry midpoint. Overall, Hadasit Bio Holdings has a GF Score™ of 14/100, reflecting its overall financial health beyond just this single metric.
How does Hadasit Bio Holdings' 3-Year ROIIC % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Hadasit Bio Holdings ranks #659 out of 1328 companies for 3-Year ROIIC %. This puts Hadasit Bio Holdings in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year ROIIC % for a Biotechnology company?
A good 3-Year ROIIC % depends on the Biotechnology industry context. However, 3-Year ROIIC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year ROIIC % mean?
A high 3-Year ROIIC % can signal that a stock is expensive relative to its fundamentals. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on Hadasit Bio Holdings and its competitors. Hadasit Bio Holdings's current 3-Year ROIIC % is -4.36. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hadasit Bio Holdings stock overvalued right now?
Hadasit Bio Holdings (HSITF) has a current 3-Year ROIIC % of -4.36. The current 3-Year ROIIC % is -4.36. Hadasit Bio Holdings' overall GF Score™ is 14/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year ROIIC % calculated?
3-Year ROIIC % is calculated from a company's financial statements. For Hadasit Bio Holdings (HSITF), the current 3-Year ROIIC % is -4.36 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Hadasit Bio Holdings Ltd serves as a precedent in the field of biotech financing. It is engaged in the advancement and enhancement of its portfolio companies. Its portfolio companies are involved in the field of medical and biotechnological research and production and distribution of the results of the research and development done in these areas.
14GF Score
Get the complete analysis for HSITF
3-Year ROIIC % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HSITF has been successfully added to your 
